Pfizer to Pay $11.6 Billion for Migraine Pill Maker Biohaven Pharmaceuticals
Pfizer and Biohaven Pharmaceutical Holding Company announced on Tuesday, that they have struck an agreement under which Pfizer will acquire
Read more
Deals
Sanofi and Exscientia Partner to Develop AI-driven Pipeline of Precision-Engineered Medicines
French pharma giant Sanofi and British pharmatech business Exscientia revealed a ground-breaking research cooperation and licensing agreement to develop up
Read more
Aerogen and CanSinoBIO Partner to Develop the First Inhaled COVID-19 Vaccine
The award-winning Ireland-based medical device company Aerogen and the innovative Chinese vaccine company CanSinoBIO entered into a partnership earlier this
Read more
Japan to Buy 1.6 Mill Courses of Merck’s Oral COVID-19 Antiviral Molnupiravir
Merck (MRK) and Ridgeback Biotherapeutics have announced that the Japanese government will acquire approximately 1.6 million courses of molnupiravir (MK-4482,
Read more
SCIEX and Evosep Collaborate to Enhance High-Throughput Proteomics
SCIEX and Evosep have established a collaboration to co-market solutions designed to enhance the stability of high-throughput proteomics systems for
Read more
Takeda and JCR to Commercialize Next-Gen Hunter Syndrome Therapy
Takeda and JCR Pharmaceuticals announced today a geo-based exclusive collaboration and license agreement to commercialize JR-141 (INN: pabinafusp alfa), an
Read more
Boehringer Ingelheim and Twist Form Therapeutic Antibody Discovery Partnership
Boehringer Ingelheim and Twist Bioscience have entered into a research collaboration that covers multiple antibody research programs. Twist Bioscience Corporation,
Read more
Sanofi to buy Kadmon and its First-in-class Transplant Drug in $1.9B Deal
Sanofi announced that it will purchase U.S. biotech Kadmon to enhance its transplant business for approximately $1.9 billion. Sanofi and
Read more
Vertex and Arbor Collaborate to Develop Novel ex vivo Engineered Cell Therapies
Vertex Pharmaceuticals Incorporated and Arbor Biotechnologies unveiled they have entered into a new cooperation to accelerate the development of novel
Read more
Arvinas and Pfizer to Co-develop and Commercialize Breast Cancer Therapy
Arvinas and Pfizer have announced a global collaboration to develop and commercialize ARV-471, an investigational oral PROTAC® (PROteolysis TArgeting Chimera)
Read more